SAG-282

N/A

Report date: 2025/01/26 17:50:56
NME

Base Information

Drug NameSAG-282
Drug Alias NameHBsAg inhibitor (Kumamoto university)SAG-282
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHBsAg inhibitorsRNA modulators
TargetsRibonucleic AcidHepatitis B Surface Antigens
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKumamoto University
China Registration ClassN/A

Develop Information

Active CompaniesKumamoto University
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A